Efficacy and Safety Study of Clozapine Augmented by Atomoxetine Versus Clozapine Augmented by Placebo in Patients With Chronic Resistant Schizophrenia
Condition(s):SchizophreniaLast Updated:March 26, 2013Terminated
Hide Studies Not Open or Pending
Condition(s):SchizophreniaLast Updated:March 26, 2013Terminated
Condition(s):SchizophreniaLast Updated:March 14, 2022Completed
Condition(s):Attention Deficit Disorder With Hyperactivity; Substance-Related DisordersLast Updated:November 7, 2012Completed
Condition(s):ADHDLast Updated:June 22, 2010Completed
Condition(s):Attention Deficit Hyperactivity DisorderLast Updated:July 9, 2012Completed
Condition(s):Attention Deficit Hyperactivity DisorderLast Updated:March 12, 2024Recruiting
Condition(s):Alcohol-induced Cue-craving; Alcohol SensitivityLast Updated:May 31, 2012Terminated
Condition(s):Obstructive Sleep ApneaLast Updated:September 14, 2023Completed
Condition(s):Sleep ApneaLast Updated:October 17, 2023Recruiting
Condition(s):Attention Deficit Hyperactivity DisorderLast Updated:September 5, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.